These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12975556)

  • 21. Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim.
    Krečak I; Skorić I; Čengić M; Krečak F; Skelin M
    Transfus Apher Sci; 2023 Apr; 62(2):103582. PubMed ID: 36253251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple responses of aplastic anemia to low-dose cyclosporine therapy despite development of a myelodysplastic syndrome.
    Litzow MR; Kyle RA
    Am J Hematol; 1989 Nov; 32(3):226-9. PubMed ID: 2816916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of cyclosporine A treatment of patients with low-risk myelodysplastic syndrome: presence of CD55(-)CD59(-) blood cells predicts platelet response.
    Ishikawa T; Tohyama K; Nakao S; Yoshida Y; Teramura M; Motoji T; Takatoku M; Kurokawa M; Mitani K; Uchiyama T; Omine M
    Int J Hematol; 2007 Aug; 86(2):150-7. PubMed ID: 17875530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Owczarek D; Finke D; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Infection-induced transient increase in the platelet count, and a transient remission of thrombocytopenia with high-dose intravenous gammaglobulin therapy during intercurrent pneumonia in chronic idiopathic thrombocytopenic purpura].
    Katoh M; Ishikawa I; Umeda M; Tsukahara T
    Rinsho Ketsueki; 1994 Mar; 35(3):296-9. PubMed ID: 8158852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression.
    Nathanson S; Cochat P; André JL; Guyot C; Loirat C; Nivet H; Deschênes G
    Pediatr Nephrol; 2005 Dec; 20(12):1801-4. PubMed ID: 16228184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of idiopathic thrombocytopenic purpura-like syndrome in a cancer patient with low-dose interferon: case report and review of the literature.
    Tsoussis S; Ekonomidou F; Vourliotaki E; Karalis I; Dermitzakis A
    Am J Hematol; 2004 Aug; 76(4):353-9. PubMed ID: 15282668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune thrombocytopenic purpura associated with rheumatoid arthritis: case report.
    Horino T; Sasaoka A; Takao T; Taguchi T; Maruyama H; Ito H; Takemoto S; Taguchi H; Hashimoto K
    Clin Rheumatol; 2005 Nov; 24(6):641-4. PubMed ID: 15864685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune thrombocytopenia in an elderly patient treated successfully by pulse therapy with cyclophosphamide.
    Ikeda K; Shichishima T; Yui T; Sakai K; Ohtake A; Ishibashi T; Noji H; Maruyama Y
    Fukushima J Med Sci; 2001 Jun; 47(1):33-8. PubMed ID: 11764416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S; Uemura O; Nagai T; Yamakawa S; Iwata N; Ito H; Nakano M; Tanaka K
    Pediatr Int; 2015; 57(1):85-91. PubMed ID: 25225083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoimmune hemolysis accompanied by thrombopenia: consumption or myelodysplasia?].
    Melchardt T; Weiss L; Egle A
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2093-5. PubMed ID: 24085363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effective Treatment with Cyclosporine of a Ulcerative Colitis Patient with Concurrent Idiopathic Thrombocytopenic Purpura Who Subsequently Developed Spontaneous Pneumomediastinum.
    Iwasa T; Nakamura K; Ihara E; Aso A; Ito T
    Intern Med; 2017; 56(11):1331-1337. PubMed ID: 28566594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated platelet microparticle levels after acute ischemic stroke with concurrent idiopathic thrombocytopenic purpura.
    Ichijo M; Ishibashi S; Ohkubo T; Nomura S; Sanjo N; Yokota T; Mizusawa H
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):587-9. PubMed ID: 23747179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary immune thrombocytopenia accompanied by pituitary apoplexy].
    Tsuji T; Mochinaga H; Yamasaki H; Tsuda H
    Rinsho Ketsueki; 2016 Jul; 57(7):877-80. PubMed ID: 27498733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome.
    Yu QH; Shen YP; Ye BD; Zhou YH
    Platelets; 2015; 26(2):195-6. PubMed ID: 23634876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myelodysplastic syndrome accompanied by Evans syndrome].
    Takezako N; Shikai T; Tanimura A; Inokuchi C; Yamagata N; Masaki N; Miwa A
    Rinsho Ketsueki; 2003 Jun; 44(6):396-400. PubMed ID: 12884819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.